Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 11, 2011 - Issue 4
Submit an article Journal homepage
81
Views
15
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Plasma cholesterol and risk for late-onset Alzheimer’s disease

Angel Cedazo-Mínguez Department of Neurobiology, Care Sciences and Society, Karolinska Institutet–Alzheimer’s Disease Research Center, NOVUM, 5th floor, SE-14186 Stockholm, Sweden;angel.cedazo-mí[email protected]
,
Muhammad-Al-Mustafa Ismail Department of Neurobiology, Care Sciences and Society, Karolinska Institutet–Alzheimer’s Disease Research Center, NOVUM, 5th floor, SE-14186 Stockholm, Sweden; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet–Alzheimer’s Disease Research Center, NOVUM, 5th floor, SE-14186 Stockholm, Sweden
&
Laura Mateos Department of Neurobiology, Care Sciences and Society, Karolinska Institutet–Alzheimer’s Disease Research Center, NOVUM, 5th floor, SE-14186 Stockholm, Sweden; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet–Alzheimer’s Disease Research Center, NOVUM, 5th floor, SE-14186 Stockholm, Sweden
Pages 495-498 | Published online: 09 Jan 2014

References

  • Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc. Health Risk Manag.4(2), 363–381 (2008).
  • Anstey KJ, Lipnicki DM, Low LF. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry16(5), 343–354 (2008).
  • Panza F, D’Introno A, Colacicco AM et al. Lipid metabolism in cognitive decline and dementia. Brain Res. Rev.51(2), 275–292 (2006).
  • Hartmann T, Kuchenbecker J, Grimm MO. Alzheimer’s disease: the lipid connection. J. Neurochem.103(Suppl. 1), 159–170 (2007).
  • Kivipelto M, Solomon A. Cholesterol as a risk factor for Alzheimer’s disease – epidemiological evidence. Acta Neurol. Scand. Suppl.185, 50–57 (2006).
  • Kalmijn S, Foley D, White L et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese–American elderly men. The Honolulu–Asia aging study. Arterioscler. Thromb. Vasc. Biol.20(10), 2255–2260 (2000).
  • Cedazo-Minguez A. Apolipoprotein E and Alzheimer’s disease: molecular mechanisms and therapeutic opportunities. J. Cell. Mol. Med.11(6), 1227–1238 (2007).
  • Jones L, Harold D, Williams J. Genetic evidence for the involvement of lipid metabolism in Alzheimer’s disease. Biochim. Biophys. Acta1801(8), 754–761 (2010).
  • Kivipelto M, Rovio S, Ngandu T et al. Apolipoprotein E ε4 magnifies lifestyle risks for dementia: a population-based study. J. Cell. Mol. Med.12(6B), 2762–2771 (2008).
  • Solomon A, Kivipelto M. Cholesterol-modifying strategies for Alzheimer’s disease. Expert Rev. Neurother.9(5), 695–709 (2009).
  • Hirsch-Reinshagen V, Burgess BL, Wellington CL. Why lipids are important for Alzheimer disease? Mol. Cell. Biochem.326(1–2), 121–129 (2009).
  • Kandiah N, Feldman HH. Therapeutic potential of statins in Alzheimer’s disease. J. Neurol. Sci.283(1–2), 230–234 (2009).
  • Altman R, Rutledge JC. The vascular contribution to Alzheimer’s disease. Clin. Sci. (Lond.)119(10), 407–421 (2010).
  • Zlokovic BV. New therapeutic targets in the neurovascular pathway in Alzheimer’s disease. Neurotherapeutics5(3), 409–414 (2008).
  • Famer D, Meaney S, Mousavi M, Nordberg A, Bjorkhem I, Crisby M. Regulation of α- and β-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the α-secretase pathway. Biochem. Biophys. Res. Commun.359(1), 46–50 (2007).
  • Bjorkhem I, Cedazo-Minguez A, Leoni V, Meaney S. Oxysterols and neurodegenerative diseases. Mol. Aspects Med.30(3), 171–179 (2009).
  • Mateos L, Akterin S, Gil-Bea FJ et al. Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro. Brain Pathol.19(1), 69–80 (2009).
  • Ullrich C, Pirchl M, Humpel C. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Mol. Cell. Neurosci.45(4), 408–417 (2010).
  • Mateos L, Ismail MAM, Gil-Bea FJ et al. Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer’s disease. J. Alzheimer’s Dis. DOI: 10.3233/JAD-2011-101512 (2011) (Epub ahead of print).
  • Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch. Neurol.61(5), 705–714 (2004).
  • Elias PK, Elias MF, D’Agostino RB, Sullivan LM, Wolf PA. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom. Med.67(1), 24–30 (2005).
  • Reitz C, Tang MX, Schupf N et al. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch. Neurol.67(12), 1491–1497 (2010).
  • Morley JE, Banks WA. Lipids and cognition. J. Alzheimer’s Dis.20(3), 737–747 (2010).
  • Ferrannini E, Gastaldelli A, Iozzo P. Pathophysiology of prediabetes. Med. Clin. North Am.95(2), 327–339 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.